Accession Number: | 0000899243-21-025953 |
Date: | 2021-06-23 |
Issuer: | ITERUM THERAPEUTICS PLC (ITRM) |
Original Submission Date: |
DUNNE MICHAEL W.
C/O ITERUM THERAPEUTICS PLC, BLK 2
FL. 3, HARCOURT CENTRE, HARCOURT ST.
DUBLIN, L2 2
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2021-06-23 | deemed execution date | A | 36,798 (a) | ordinary shares 36,798 | $0.00 | 36,798 | direct |
ID | footnote |
---|---|
f1 | each restricted share unit ("rsu") represents the contingent right to receive one ordinary share upon vesting of the rsu. |
f2 | subject to the reporting person providing continuous service to the issuer and the other terms and conditions of the issuer's 2018 amended and restated equity incentive plan, as amended, the rsus shall vest in full on june 23, 2022. |